Compare ANIX & AGPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | AGPU |
|---|---|---|
| Founded | 1982 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.9M | 83.5M |
| IPO Year | 2013 | 2008 |
| Metric | ANIX | AGPU |
|---|---|---|
| Price | $3.00 | $7.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | 203.7K | ★ 258.5K |
| Earning Date | 09-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $210,000.00 | $125,284.00 |
| Revenue This Year | N/A | $48,110.47 |
| Revenue Next Year | N/A | $614.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $1.03 |
| 52 Week High | $5.46 | $13.49 |
| Indicator | ANIX | AGPU |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 38.00 |
| Support Level | $2.77 | $7.42 |
| Resistance Level | $3.09 | $9.38 |
| Average True Range (ATR) | 0.18 | 0.76 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 47.65 | 19.07 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.